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A Therapeutic Vaccine Approach
to Stimulate Axon Regeneration
in the Adult Mammalian Spinal Cord
regeneration in long fiber tracts in the adult rat spinal
cord (Schnell and Schwab, 1990; Bregman et al., 1995),
the number of axons that regenerate is small and likely
reflects the presence of other inhibitors (reviewed by
David, 1998). In addition to the already identified inhibi-
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Canada of myelination extends the period of regenerative growth
in the developing rat and avian spinal cord (Savio and
Schwab, 1990; Keirstead et al., 1995). Axon growth in-
Summary hibitors associated with the scar at the injury site also
appear to be important contributors to regeneration fail-
Axon growth inhibitors associated with myelin play an ure (McKeon et al., 1991; Pindozolla et al., 1993; Davies
important role in the failure of axon regeneration in et al., 1997; Wang et al., 1997). For example, proteogly-
the adult mammalian central nervous system (CNS). cans expressed by astrocytes at the site of lesion have
Several inhibitors are present in the mature CNS. We strong neurite growth inhibitory activity (McKeon et al.,
now present a novel therapeutic vaccine approach in 1991).
which the animals' own immune system is stimulated Achievement of a substantial measure of axonal re-
to produce polyclonal antibodies that block myelin- generation in the CNS will require blocking several of
associated inhibitors without producing any detrimen- these axon growth inhibitors. Here, we present a simple
tal cellular inflammatory responses. Adult mice immu- and effective therapeutic vaccine approach to stimulate
nized in this manner showed extensive regeneration the animals' own immune system to generate polyclonal
of large numbers of axons of the corticospinal tracts antibodies that block the inhibitory properties of the
after dorsal hemisection of the spinal cord. The ana- CNS and thus permit profuse long-distance regenera-
tomical regeneration led to recovery of certain hind tion of corticospinal tract fibers in the adult mouse spinal
limb motor functions. Furthermore, antisera from im- cord. Furthermore, the immunization protocol employed
munized mice were able to block myelin-derived inhib- was such that it did not result in the production of a
itors and promote neurite growth on myelin in vitro. cellular inflammatory response.
ResultsIntroduction
Regeneration of Corticospinal Fibers AssessedThe failure of injured axons to regenerate long distances
by Anterograde Labelingin the adult mammalian CNS leads to permanent paraly-
Adult female BALB/c mice (8±10 weeks old) were immu-sis and other functional deficits such as those seen after
nized twice weekly with a homogenate of mouse spinalspinal cord injuries. Although axons do not regenerate
cord (which is rich in myelin and contains some inhibitorythrough adult CNS tissue, they retain the ability to re-
proteoglycans; Pindozolla et al., 1993; Wang et al., 1997)grow for long distances if provided with an appropriate
in incomplete Freund's adjuvant (IFA). Control mice werecellular environment, e.g., a peripheral nerve graft (David
injected with IFA alone. As discussed later, the use ofand Aguayo, 1981). Work by Schwab and his colleagues
IFA for the immunizations avoids the production of un-led to the discovery that the failure of axons to regener-
wanted inflammatory demyelinating lesions. Three weeksate through CNS tissue was likely to be due in large
later, the spinal cords were hemisected dorsally to lesionpart to the influence of axon growth inhibitory activity
both corticospinal tracts at the lower thoracic cord (T9)associated with myelin (Caroni and Schwab, 1988; re-
level. Care was taken to assure consistency of the depthviewed by Schwab et al., 1993). A monoclonal antibody
of the lesion as described in the Experimental Proce-(IN-1) was shown to recognize a 250/35 kDa glycopro-
dures. After a further 3 weeks, during which the animalstein in myelin which has axon growth inhibitory proper-
continued to receive twice weekly immunizations, re-ties (Schwab et al., 1993). Although blocking this inhibi-
generation of the corticospinal tracts was assessed usingtor with the IN-1 monoclonal antibody stimulates axon
the anterograde neuronal tracer wheatgerm agglutinin±
conjugated horseradish peroxidase (WGA-HRP) injected§ To whom correspondence should be addressed (e-mail: mcsl@
musica.mcgill.ca). into the sensory±motor cortex (Li et al., 1996). About
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Figure 1. Regeneration of Corticospinal Tract
Axons
In (A) through (F), (I), and (J), rostral is located
toward the left side and caudal is located
toward the right side.
(A) Micrograph of a longitudinal section of
the lesioned corticospinal tract in a mouse
immunized with spinal cord homogenate in
IFA. WGA-HRP labels the tract rostral and
caudal to the lesion (arrow). Many regener-
ated axons can be seen caudally.
(B) Higher magnification of an adjacent sec-
tion showing the scar at the site of lesion.
WGA-HRP-labeled axons can be seen cours-
ing through the scar (arrow; the same area is
shown at higher magnification in the inset). A
large number of HRP-labeled fibers that have
regenerated caudal to the lesion (arrowhead)
have bypassed the scar.
(C) Dark-field micrograph showing a bundle of regenerated axons (between arrows) 7.5 mm caudal to the lesion in an immunized mouse.
(D) Montage of two adjacent longitudinal tissue sections from another immunized animal in which most of the WGA-HRP-labeled fibers in the
tract course through the area of lesion (asterisk), making a kink-like displacement. Caudal is located to the right side of the lesion.
(E) A bright-field image of one of the sections from which the montage in (D) was made. Note the lesion at the center (asterisk), which is seen
as the area of high cellularity. In contrast, the dorsal columns away from the lesion, which are seen toward the right and left margins of the
micrograph, have markedly fewer cells and a paler appearance.
(F and I) Longitudinal sections through the spinal cord of a control mouse injected with IFA (F) and a control mouse injected with liver
homogenate in IFA (I). WGA-HRP-labeled axons of the corticospinal tract stop at the site of lesion in both cases. Note that the scar at the
site of lesion is minimal in the liver control (I).
(G) Fluorogold-labeled neurons in the motor cortex in a mouse immunized with bovine myelin in IFA.
(H) The same field as in (G) showing neurons double labeled with Fluororuby.
(J) Longitudinal section through the spinal cord of a mouse immunized with mouse myelin that showed double-labeled cortical motor neurons.
This section shows that the two fluorescent markers in the spinal cord remain widely separated from each other. The Fluorogold labeling
spread over a greater distance than Fluororuby because it was injected directly into the lesion at the time of hemisectioning. However, the
amount of spreading was similar in immunized and control mice. The signal for Fluororuby appears weak in this micrograph because it was
photographed at a very low magnification.
Scale bars: 300 mm (A, F, and I); 200 mm (B, D, and E); 100 mm (C); 50 mm (G, H, and inset); and 1 mm (J).
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for any further analysis. The percentage of control mice
showing moderate to severe scarring was similar to that
seen in immunized mice (z60%). Only one of the control
mice showed lesion-induced cavitations. As an addi-
tional control, mice were immunized with mouse liver
homogenate in IFA (n 5 4). Three weeks after spinal
cord dorsal hemisection, WGA-HRP injections into the
sensory±motor cortex of these mice did not result in any
labeling of corticospinal tract axons caudal to the lesion
(Figure 1I), indicating the specificity of the myelin-rich
spinal cord homogenate in stimulating axon regenera-
tion. To further confirm that the WGA-HRP-labeled ax-
ons that crossed the lesion in the immunized mice were
indeed lesioned axons that had regenerated and not
Figure 2. Maximum Length of Regenerating Axons ones that might have been spared, retrograde double
The maximum distance that injured corticospinal tract axons regen- labeling studies were carried out on a separate group
erated caudal to the site of lesion in mice immunized with mouse of animals.
spinal cord homogenate in IFA (ªIMº) and controls injected with IFA
alone (ªCº). This distance was estimated from serial sections and
Regeneration of Corticospinal Fibers Assessedby measuring the maximum distance to which WGA-HRP-labeled
by Retrograde Labelingaxons extended caudally. Each point represents one animal.
Since myelin-associated inhibitors have been reported
to play a crucial role in the failure of CNS regeneration,
we compared the effects of spinal cord homogenate54% percent of the immunized mice (n 5 13) showed
abundant WGA-HRP labeling of corticospinal tract ax- (n 5 6) with myelin purified from either mouse (n 5 12)
or bovine (n 5 4) CNS. The same immunization andons across the lesion and for long distances caudally
past the lesion (Figures 1A±1E and 2). The maximum lesioning protocol as that described above was used in
these experiments, and the retrograde tracer Fluorogolddistance these labeled axons extended varied in differ-
ent animals and ranged from 5 mm to about 11 mm from (Schmued and Fallon, 1986; Novikova et al., 1997) was
injected at the site of lesion to label cut corticospinalthe lesion (Figure 2). A large number of these axons
extended about 6 mm and a few reached about 11 mm. tract axons. Our studies with the unlesioned corticospi-
nal tract (n 5 2) as well as previous work (SchmuedRegenerated axons were located in the myelinated dor-
sal columns caudal to the lesion. Some of these axons and Fallon, 1986) indicate that following injection of this
tracer into the white matter it is not taken up by axonsappeared to be displaced more dorsal to their normal
position but along the boundary with the gray matter of passage. Fluorogold can be taken up by synaptic
terminals but injection of this tracer into the ventral gray(data not shown). Although axons appeared to bypass
the scar in some animals, in others many axons ex- matter at T9 without damage to the corticospinal tract
resulted in only about 20% of the cortical motor neuronstended through the scar at the lesion site (Figures 1A±
1E). The presence of the lesion and the scar was easily being labeled as compared to the labeling seen after
lesion of the tract at the same level. Importantly, verydetected by the cellular nature of the scar as revealed
by the neutral red staining (Figures 1B and 1E). The few of the axons that have terminals at the T9 level
project 6 mm caudally (see below). The neuronal labelinglesioned axons made a kink-like displacement upwards
as they passed through the region of the scar. The le- after injection into the terminal field was also much
weaker than after injection into the lesioned tract. Takensions of the corticospinal tract were judged to be com-
plete in all treated animals, based on these criteria. Fur- together, these data indicate that Fluorogold reliably
labels axotomized corticospinal neurons. Two weeksthermore, the variability in the maximum length the
WGA-HRP-labeled axons extended caudal to the lesion after dorsal hemisection, a second tracer (Fluororuby
[Novikova et al., 1997] or cholera toxin subunit B [Ta-indicates that these are indeed regenerated axons (Fig-
ure 2). Uncut, spared axons would be expected to ex- vares et al., 1996]) was injected directly into the cortico-
spinal tract about 6 mm caudal to the lesion. Thesetend throughout the spinal cord caudal to the injury.
Two of the six immunized mice in which regeneration injections would thus cause damage to the fibers in the
corticospinal tract. Animals were sacrificed 1 week laterfailed had cavitations at the lesion site and two mice
had well-formed scars. In contrast to the immunized (i.e., total survival time of 3 weeks post lesion) and cryo-
stat sections of the motor cortex examined for the pres-mice, no WGA-HRP-labeled axons were seen caudal to
the lesion in nine control mice injected only with IFA. ence of double-labeled neurons. As with the WGA-HRP
labeling studies, 55% of the mice immunized with spinalThe depth of the lesion and the characteristics of the
scar as judged by the neutral red staining was similar cord homogenate or purified myelin showed good evi-
dence of regeneration of corticospinal tract axons asin both the immunized and control groups. Of all the
animals used for anterograde tracing, only one control revealed by the presence of double-labeled neurons in
the sensory±motor cortex (Figures 1G, 1H, and 3). Inmouse had an incomplete lesion. In this mouse, a small
number of axons in the ventralmost portion of the tract mice that demonstrated strong evidence of axon regen-
eration, 50% 6 16% of the motor neurons were doublewere not lesioned and could be seen extending straight
across, just ventral to the lesion without making a kink- labeled (i.e., regenerated neurons). In some mice, as
high as 75% of the neurons were double labeled (Figurelike displacement. This mouse was therefore not used
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Figure 3. Percentage of Double-Labeled Neurons in the Motor Cor-
tex Retrogradely Labeled with Fluorogold and Fluororuby
Data from four groups are shown. These include mice immunized
with mouse spinal cord (ªMouse SCº), mouse myelin, and bovine
myelin and controls injected with IFA. These data are an indication
of the proportion of lesioned corticospinal tract neurons that regen-
erated their axons.
3). Previous studies have shown that injection of two
fluorescent tracers into the terminal field of the cortico-
spinal tract (ventral gray) in rats at about the same two
spinal cord levels as that used here (without damage to
the tract) results in only 1.6% of the cortical motor neu-
rons being double labeled (Akinsegun and Buxton,
1992). We also obtained a low percentage of double-
labeled neurons after similar injections in the mouse at
T9 and 6 mm caudally (5%, n 5 2). Therefore, if double Figure 4. Serum Immunoglobulin
labeling were to occur in the lesioned spinal cord of (A and B) Enzyme-linked immunosorbent assays show that the levels
immunized mice via collaterals of uninjured axons, the of IgG (A) and IgM (B) in sera of mice immunized with mouse spinal
numbers are not likely to be greater than 5%. The aver- cord homogenate (ªIMº) is higher than in controls (ªCº).
age of 50% and high of 75% of double-labeled neurons (C) Sera from immunized mice also show strong myelin reactivity
as compared to sera from controls.seen in the immunized mice, therefore, indicates a sub-
stantial degree of axon regeneration. Only 6% of the
motor neurons in immunized mice were labeled with the
second marker alone (i.e., unlesioned or spared neu- of the hind limbs. These results indicate that anatomical
rons). In the majority of these animals (60%), less than regeneration led to functional recovery.
1% of the neurons were spared. Double-labeled neurons
were rarely seen (0.19%) in control animals with spinal
cord hemisection (n 5 9) (Figure 3). There was no evi- Myelin-Reactive Antibodies in the Serum
dence that double labeling could have occurred by and Spinal Cord of Immunized Mice
spreading and mixing of the two fluorescent tracers as Higher levels of IgG and IgM were present in the serum
confirmed by the wide separation of the two labels in of immunized mice than in controls (Figures 4A and 4B).
longitudinal sections of the spinal cord (Figure 1J). The
Serum immunoglobulin in immunized mice reacted with
extent of diffusion of the two labels was also the same
myelin and spinal cord proteins as detected by ELISAin immunized and control mice. These results provide
(Figure 4C) and Western blotting (Figure 5A). Immuno-strong evidence that injured corticospinal tract axons
globulin was also detected by immunofluorescence incan regenerate in mice immunized with a homogenate
the lesioned spinal cord of both immunized and controlof tissue rich in myelin or with purified CNS myelin in IFA.
mice. However, the staining in immunized mice was
much stronger and extended for far longer distancesFunctional Recovery in Immunized Mice
(5 mm) on either side of the lesion compared to controlsRecovery of motor control of the hind limbs was as-
when examined 3 days after hemisection. Furthermore,sessed 3 weeks after lesioning in a group of mice immu-
immunoglobulin staining in immunized mice was espe-nized with mouse myelin or controls (injected with IFA
cially prominent along the dorsal white matter, where itonly) using the contact placing test. Mice that showed
appeared to be localized to myelin (Figures 5B and 5C).anatomical evidence of axon regeneration also showed
The immunization protocol that we used resulted in theimprovement in function. Contact placing of the hind
production of antibodies without stimulating inflamma-limbs in response to light touch of the dorsal surface of
tory changes in the CNS. There was no evidence ofthe hind limbs, without joint displacement, was detected
infiltration of inflammatory cells or demyelination similarin 58% of the immunized mice but in none of the control
to that seen in experimental allergic encephalomyelitismice. The contact placing response is dependent upon
(EAE) in Epon-embedded tissue sections of the spinalthe integrity of the corticospinal tract (Kunkel-Bagden
et al., 1993) and is widely used to assess motor control cord of immunized mice (Figures 5D and 5E).
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Figure 6. Antisera from Immunized Mice Neutralize Myelin-Associ-
ated Inhibition of Neurite Growth
(A) Antisera from immunized mice block the neurite growth inhibitory
effects of CNS myelin. Neurite growth on myelin is significantly
longer in wells treated with sera from immunized mice (ªIM1º through
ªIM4º) compared to control mice (ªCº). Data represent the mean 6
SEM from two separate experiments. The data from three control
mice were pooled. The mean values for all immunized mice are
significantly greater than for controls (p # 0.05); the difference be-
tween the mean values for ªIM2º and ªIM4º is also statistically signifi-
cant (p # 0.05).
Antisera from Immunized Mice Are Able
to Stimulate Neurite Growth on Myelin
Additional experiments were carried out to assess if the
myelin-reactive antibodies in the serum of immunized
mice were able to block the neurite growth inhibitory
activity associated with CNS myelin. Tissue culture sub-
strates coated with CNS myelin were incubated over-
night with serum from the mice used for the retrograde
double labeling studies described above. Neurite growth
on these myelin substrates was assessed using purified
neonatal rat cerebellar neurons. The length of the neu-
rites on myelin treated with serum from control mice
averaged about 7 mm. In contrast, sera from four mice
immunized with mouse CNS myelin were able to signifi-
cantly increase neurite growth on myelin. The averageFigure 5. Binding of Antibodies to Spinal Cord and Lack of Inflam-
length of the neurites in wells treated with these fourmatory Cell Responses
antisera ranged from 20±27 mm. Antisera from two im-(A) Western blot of spinal cord proteins showing an example of the
munized mice that were positive in the double labelingbinding of the sera from an immunized mouse (left lane) and a control
mouse (right lane), both of which were sacrificed 3 weeks after experiments showed the longest neurite growth (IM3
spinal cord hemisection. The antibodies in the sera of immunized and IM4 in Figure 6). Antisera from the other two immu-
mice bound variably to multiple bands (not yet identified) as com- nized mice (IM1 and IM2 in Figure 6), which were nega-
pared to controls. MW markers (arrowheads): 103, 76, and 49 kDa. tive in the double labeling study, also blocked inhibitors
(B) Staining for mouse immunoglobulin in tissue sections of the
associated with myelin but to a lesser extent. To furtherspinal cord from a mouse immunized with mouse spinal cord ho-
confirm that the serum effects were mediated by anti-mogenate in IFA and sacrificed 3 days after hemisection. Micrograph
bodies, IgGs and IgMs were immunodepleted from thetaken about 2 mm caudal to the lesion from an area through the
serum (of mouse IM3) with goat anti-mouse IgG1IgMdorsal column shows strong labeling of myelin.
(C) A similar area through the spinal cord of a control mouse taken conjugated to agarose beads (Affi-Gel-10, BioRad). The
3 days after hemisection. depletion of the samples was effective as determined
(D) Toluidine blue±stained Epon-embedded section of the cervical by ELISA (Figure 7A). The predepleted and depleted
spinal cord of an immunized mouse shows no evidence of demyelin- serum samples, as well as the antibodies eluted from the
ation or infiltration of immune cells into the CNS or submeningeal
agarose beads, were used to incubate myelin-coatedspace. Axonal degeneration is only seen in the fasciculus gracilis
substrates prior to plating neurons for neurite growthwhose fibers were severed by the lower thoracic cord hemisection.
assays as described above. Immunodepletion of theThis appears as an area of darker staining (due to the disruption of
the myelin) in the midline of the dorsal columns. antibodies from the serum resulted in a loss of the ability
(E) Higher magnification of ventral white matter shows no evidence of the serum from the immunized mouse to block the
of inflammatory changes. neurite growth inhibitory activity associated with myelin
Scale bars: 50 mm (B and C); 200 mm (D); and 100 mm (E). (Figure 7B). In addition, this neurite growth inhibitory
activity could be blocked by the eluted antibodies (Fig-
ure 7B). These results indicate that the antibodies gener-
ated in the immunized mice are indeed able to block
axon growth inhibitors associated with myelin.
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myelin proteins in IFA has been shown to protect animals
from EAE (O'Neill et al., 1992; Rivero et al., 1997; Tone-
gawa, 1997), which is a T cell±mediated disease. Protec-
tion by this and related types of treatment is thought
to be due to clonal deletion and immune deviation of
autoreactive T cells (Gaur et al., 1992; Weiner et al.,
1994).
It was shown recently that adult rodent dorsal root
ganglion cells microinjected into the adult rat CNS are
able to grow axons for long distances along myelinated
fiber tracts until they reach the site of a CNS lesion
(Davies et al., 1997, 1999). It is therefore possible that
myelin-derived inhibitors and astroglial proteoglycans
may act primarily at the site of lesion, where rapid myelin
breakdown leads to exposure of inhibitors (Tang et al.,
1997) and also where astrocytes deposit proteoglycans
(McKeon et al., 1991). Work by Schwab's group, how-
ever, suggests that some myelin-associated inhibitors
act along the entire course of myelinated fiber tracts
(Schwab and Schnell, 1991). Since we find that immuni-
zation with purified myelin is effective in stimulating re-
generation, this effect could be due to blocking of my-
elin-associated inhibitors leading to axon regeneration
across the lesion before the full expression of inhibitory
proteoglycans occurs at the lesion site. On the other
hand, we have evidence that some astrocyte-derived
inhibitors copurify with myelin (unpublished data), and
these molecules may also be blocked under our immuni-Figure 7. Antibodies Mediate the Blocking Effect of Serum
zation conditions. Clearly, antibodies that were gener-
(A) ELISA showing the level of IgG and IgM in the serum of an
ated in the immunized mice were found to bind to myelinimmunized mouse (ªPredepletedº) and after immunodepletion (ªDe-
in the white matter after spinal cord hemisection. Inpletedº) and the recovery of these antibodies after elution from the
agarose beads (ªElutedº), as described in the Experimental Proce- addition, there was also much widespread antibody la-
dures. beling at the lesion site in both the immunized and con-
(B) Histogram showing the effects of the samples shown in (A) on trol mice (due to the direct effect of the lesion on the
neurite growth on myelin. Compared to growth on untreated myelin- blood±brain barrier), but it is not known whether these
coated substrates (ªMyelinº), the length of neurites is increased by
antibodies in the immunized mice bound to specificincubating the myelin substrates with serum from the immunized
components of the scar. Importantly, the sera from im-mouse (ªPredepletedº). Neurite growth is significantly reduced after
depleting the antibodies (ªDepletedº). Additionally, the length of munized mice were able to block the neurite growth
neurite growth is increased by treating the myelin substrates with inhibitory effects of CNS myelin in vitro. In addition,
the eluted antibodies (ªElutedº). The differences between the myelin the immunodepletion studies indicate that the blocking
and the predepleted and eluted groups are statistically significant effect of the serum was mediated by antibodies.
(p # 0.05). Mean 6 SEM of two experiments.
The reasons for the failure of regeneration in some of
the immunized mice are not clear at present, but there
are several possible explanations. One factor could beDiscussion
variability in the immune response. Second, two of the
negative mice in the HRP labeling study had injury-These experiments demonstrate that a simple thera-
induced cavitations near the lesion and two had well-peutic vaccine approach can be used to stimulate exten-
formed scars. It is important to note, however, that thesive regeneration of large numbers of axons of long fiber
percentage of mice showing scarring and cavitation wastracts after spinal cord injuries. The anterograde and
similar in the immunized and control groups. For reasonsretrograde labeling studies clearly demonstrate that in-
that are not fully understood at present, lesion-inducedjured axons had indeed regenerated. The anatomical
cavitations do not occur often and as extensively afterevidence of regeneration was accompanied by recovery
spinal cord lesions in mice (Li et al., 1996) as comparedof hind limb motor control. Furthermore, the immuniza-
to rats (Neumann and Woolf, 1999). In addition to thetion protocol led to the production of myelin-reactive
presence of inhibitory proteoglycans that can preventantibodies that were shown to be capable of neutralizing
axon growth (McKeon et al., 1991; Davies et al., 1997),axon growth inhibitors present in CNS myelin.
some scars produced by such penetrating lesions canThe mice in the present study did not show any evi-
contain a leptomeningeal±astroglial interface (glia lim-dence of cellular inflammatory changes in the spinal
itans) (Li and David, 1996), which could provide a physi-cord similar to those seen in EAE. Induction of EAE in
cal barrier to axon growth. Therefore, in addition tomost rodents requires immunization with myelin pro-
blocking myelin-associated inhibitors, efforts to controlteins mixed with complete Freund's adjuvant often along
the fibrotic scar, to block inhibitory proteoglycans ex-with pertussis toxin (Traugott et al., 1985; Goverman et
al., 1997). In fact, pretreatment of mice with myelin or pressed in these regions, and to prevent tissue necrosis
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on the tip of the microscissors. After cutting the dorsal part of theresulting in cavitations will be required to achieve regen-
spinal cord with the microscissors, the completeness of the lesioneration in a larger percentage of animals.
was further assured by passing a 0.2 mm thick microdissection knifeWe have demonstrated that not only does the immuni-
(Fine Science Tools) across the cut dorsal half of the spinal cord at
zation procedure lead to increased levels of circulating the same depth. Mice continued to receive twice weekly immuniza-
myelin-reactive antibodies but that these antibodies tions for another 3 weeks. After this 3 week survival period post
lesion, the mice were anesthetized and a 5% solution (w/v) of WGA-cross the blood±brain barrier in the hemisected spinal
HRP (Sigma) was injected into the sensory±motor cortex as de-cord and then bind to myelin in the white matter. Previ-
scribed previously (Li et al., 1996). Forty-eight hours after injectionous studies have shown that contusion injury to the
of WGA-HRP, the animals were sacrificed by intracardiac perfusion,adult rat spinal cord results in increased permeability
and longitudinal cryostat sections of the spinal cord were reacted
of the blood±spinal cord barrier for about 30 mm on for HRP histochemistry as described previously (Li et al., 1996).
either side of the lesion (Popovich et al., 1996). The same
study also showed a secondary increase in blood±spinal Retrograde Neuronal Double Labeling
At the time of the spinal cord hemisection in 8- to 10-week-oldcord permeability specifically in the white matter at
female BALB/c mice, 0.5 ml of a 5% (w/v) solution of Fluorogold14±28 days post injury (Popovich et al., 1996). In addition
(Molecular Probes) was injected into the site of lesion. Two weeksto the acute breakdown of the blood±brain/spinal cord
later, the mice were anesthetized and a laminectomy was donebarrier immediately after injury, at later stages this bar-
about 6 mm caudal to the site of hemisection. A single injection of
rier may be opened by the action of microglia (Popovich 0.1±0.2 ml of 25% (w/v) solution of Fluororuby (10,000 MW, lysine
et al., 1996; Jensen et al., 1997). Therefore, the myelin- fixable; Molecular Probes) was injected directly into the corticospi-
nal tract at this level with a micropipette in most of the mice. Thisreactive antibodies that are produced by our immuniza-
injection would damage the fibers in the corticospinal tract. In twotion procedure are likely to enter into the degenerating
of the mice immunized with bovine myelin, 0.2 ml of a 1% solution offiber pathways in the white matter as the blood±brain
cholera toxin subunit B (List Biological Labs) was injected insteadbarrier is opened by the trauma and the action of acti-
of Fluororuby. No differences were seen in the results using these
vated microglia. These antibodies then bind to inhibitors two tracers. One week later (i.e., 3 weeks post lesion), animals were
associated with myelin and thus stimulate axon regener- anesthetized and perfused with 4% paraformaldehyde. Cryostat
sections (30 mm) through the sensory±motor cortex were examinedation over long distances. Further evidence that this is
with a Leitz fluorescence microscope. Tissue sections of mice in-likely to occur was provided by the in vitro experiments,
jected with cholera toxin were processed for immunofluorescencewhich showed that the antisera from the immunized
detection. Counts of labeled neurons were made from every thirdmice were indeed able to block the neurite growth inhibi-
tissue section, and only large neuronal profiles through the cell
tory effects of CNS myelin. nucleus were counted. On average, about 1000 neurons were
In the present study, we have tested the effects of counted in each animal. Longitudinal sections of the spinal cord
were also cut and examined with a fluorescence microscope tothis immunization procedure on animals with acute spi-
visualize the size and location of Fluorogold and Fluororuby injec-nal cord injuries. Animals with chronic or long-standing
tions.lesions will likely require additional manipulations to re-
move the scar and to induce the chronically lesioned
Functional Testing
neurons into a growth mode (Hagg et al., 1988; Tetzlaff Contact placing response was tested by lightly touching the dorsal
et al., 1991; Ye and Houle, 1997). By immunizing with aspect of the hind limb without causing joint displacement. The
purified myelin that contains axon growth inhibitors we ability of the animals to lift the foot and place it onto the support
surface was then assessed in three to six repetitions. Greater thanhave demonstrated that a simple, noninvasive therapeu-
a 30% response was scored as positive (Kunkel-Bagden et al., 1993).tic vaccine approach can be used to stimulate axon
regeneration after spinal cord injuries in adult mice. Ap-
ELISAplication of such an approach in humans will require
Serum from immunized and control mice was collected prior to
further refinement and testing of the immunogen. This perfusion 3 weeks after hemisection. ELISA for serum IgG and IgM
will likely involve identification of many of the inhibitors was carried out using a standard protocol with an isotyping kit from
associated with myelin and the scar, and the use of a Southern Biotechnology Associates (Birmingham, AL). For binding
to myelin, 10 mg of mouse myelin was plated onto poly-L-lysine-cocktail of these inhibitors in purified or recombinant
coated 96-well plates. After blocking the substrate with 3% bovineform as the vaccine. Alternatively, identifying the block-
serum albumin (BSA), the wells were incubated with test sera ating antibodies could also lead to the development of
1:40. Antibody binding was detected using a secondary antibody
passive immunization approaches to stimulate axon re- conjugated to alkaline phosphatase. Western blots were done as
generation. we have described previously (McKerracher et al., 1994).
ImmunohistochemistryExperimental Procedures
Three days after spinal cord hemisection, immunized and control
mice were perfused with 4% paraformaldehyde, and 10 mm thickImmunization and Spinal Cord Lesioning
longitudinal cryostat sections of the spinal cord were picked up onMouse and bovine CNS myelin were prepared as previously de-
gelatin-coated glass slides. The sections were incubated with ascribed (McKerracher et al., 1994; Li et al., 1996) and resuspended
biotinylated goat anti-mouse antibody (1:200) overnight and thenin phosphate buffered saline (PBS). Homogenates of adult BALB/c
with streptavidin-conjugated fluorescein (1:200) for 1 hr, to detectmouse spinal cord and liver were prepared in PBS. Eight- to ten-
circulating antibodies that would have leaked into the spinal cordweek-old female BALB/c mice were immunized twice weekly with
tissue due to lesion-induced breakdown of the blood±brain barrier.50 mg of either of these preparations emulsified in an equal volume
of IFA (Gibco BRL) by subcutaneous injection in the region of the
back. After 3 weeks, the mice were anesthetized with Somnitol (1 Neurite Growth Assay
96-well plates were first coated with solubilized nitrocellulose andmg/20 g body weight), and a lower thoracic laminectomy was done
(T9). The dorsal half of the spinal cord was then cut with a pair of preincubated with 5 mg/ml poly-L-lysine (Sigma). Purified bovine
CNS myelin (0.2 mg) in a 2 ml drop was placed in the center of thesemicroscissors to sever the corticospinal tracts. The depth of the
lesion, which was about 0.5 mm, was estimated by a mark placed wells and incubated for 4 hr at 378C. These wells were then incubated
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overnight at 48C with serum (1:50) from either control mice or mice of cholinergic neurons after acute brain damage. Exp. Neurol. 101,
303±312.immunized with mouse CNS myelin. The serum was removed, and
postnatal day 10 rat cerebellar neurons purified by Percoll density Jensen, M.B., Finsen, B., and Zimmer, J. (1997). Morphological and
gradient centrifugation were plated at a density of 1 3 105 cells per immunophenotypic microglial changes in the denervated fascia
well (Li et al., 1996). The cells were cultured in serum-free chemically dentata of adult rats: correlation with blood-brain barrier damage
defined medium (Li et al., 1996) for 24 hr, fixed with 4% paraformal- and astroglial reactions. Exp. Neurol. 143, 103±116.
dehyde, and stained with Coomassie blue. Neurite length was mea- Keirstead, H., Dyer, J.K., Sholomenko, G.N., McGraw, J., Delaney,
sured in one or two wells from two separate experiments using a K.R., and Steeves, J.D. (1995). Axonal regeneration and physiologi-
Universal Image I image analysis system. Data were analyzed using cal activity following transection and immunological disruption of
the Student-Newman-Keul's test to determine statistically signifi- myelin within the hatchling chick spinal cord. J. Neurosci. 15, 6963±
cant differences. 6974.
Kunkel-Bagden, E., Dai, H.-N., and Bregman, B.S. (1993). Methods
to assess the development and recovery of locomotor function afterImmunodepletion
spinal cord injury in rats. Exp. Neurol. 119, 153±164.Six milligrams of goat anti-mouse IgG1IgM (Jackson Immunore-
search) was conjugated to 2 ml of Affi-Gel-10 beads according to Li, M., and David, S. (1996). Topical glucocorticoids modulate the
the manufacturer's instructions. IgGs and IgMs from the serum (40 lesion interface after cerebral cortical stab wounds in adult rats.
ml diluted 1:25 in PBS) from an immunized mouse were immunode- Glia 18, 306±318.
pleted by incubating with 1 ml of the goat anti-mouse antibody- Li, M., Shibata, A., Li, C., Braun, P.E., McKerracher, L., Roder, J.,
conjugated Affi-Gel-10 beads for 18 hr at 48C. The beads were Kater, S.B., and David, S. (1996). Myelin-associated glycoprotein
centrifuged, and the supernatant consisting of the depleted sample inhibits neurite/axon growth and causes growth cone collapse. J.
was collected. The beads were loaded onto a column and washed Neurosci. Res. 46, 404±414.
in Tris buffered saline, and the bound antibodies were eluted with McKeon, R.J., Schreiber, R.C., and Silver, J. (1991). Reduction of
a low pH buffer (200 mM glycine [pH 2.5]) and immediately neutral- neurite outgrowth in a model of glial scarring following CNS injury
ized with Tris buffer (pH 11). The eluted antibodies were then dia- is correlated with the expression of inhibitory molecules on reactive
lyzed and concentrated. ELISAs were carried out on these samples astrocytes. J. Neurosci. 11, 3398±3411.
to determine the extent of immunodepletion and recovery of eluted
McKerracher, L., David, S., Jackson, D.L., Kottis, V., Dunn, R.J., andantibodies. These samples were then used to preincubate myelin-
Braun, P.E. (1994). Identification of myelin-associated glycoproteincoated substrates used for neurite growth assays as described
as a major myelin-derived inhibitor of neurite growth. Neuron 13,above. Neurite growth was quantified as noted above.
805±811.
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